{
    "2019-05-30": [
        [
            {
                "time": "",
                "original_text": "泰格子公司方达控股港交所挂牌，CRO市场两者应外合，各赚所需！",
                "features": {
                    "keywords": [
                        "泰格",
                        "方达控股",
                        "港交所",
                        "挂牌",
                        "CRO市场"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泰格医药境外子公司「方达控股」今日在港交所上市",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "方达控股",
                        "港交所",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "方达控股超购90.7倍，今日在港交所上市",
                "features": {
                    "keywords": [
                        "方达控股",
                        "超购",
                        "港交所",
                        "上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}